dr. lenz on the changing landscape of metastatic colorectal cancer
Published 5 years ago • 925 plays • Length 2:04Download video MP4
Download video MP3
Similar videos
-
1:35
dr. eng on the treatment landscape in metastatic colorectal cancer
-
0:26
copy of dr. eng on the treatment landscape in metastatic colorectal cancer
-
1:19
dr. lenz on need for new treatment strategies in colorectal cancer
-
1:20
dr. heinz-josef lenz explores kras/nras mutations in metastatic colorectal cancer
-
1:13
dr. lenz on breakthrough designation of encorafenib, binimetinib, and cetuximab in braf crc
-
1:12
dr. lenz on choosing between regorafenib and tas-102 in crc
-
1:00
dr. lenz on next steps with immunotherapy in mcrc
-
1:14
dr. lenz on updated results of the checkmate-142 trial in mcrc
-
2:24
dr. lenz on optimal sequencing strategies in crc
-
1:54
dr. lenz on updated data from checkmate 142 with nivolumab ipilimumab in mcrc
-
3:02
final thoughts on the treatment of metastatic colorectal cancer
-
2:13
dr. lenz on the benefit of regorafenib in crc
-
1:27
dr. lenz on later-line combo approaches in crc
-
7:20
treating metastatic colorectal cancer: case study review
-
11:41
treating unresectable metastatic colorectal cancer
-
0:53
dr. lenz on potential for immunotherapy in mcrc
-
13:11
treatment sequencing in metastatic colorectal cancer
-
9:05
determining optimal treatments in metastatic colorectal cancer
-
0:53
dr. lenz on the safety profile of checkmate-142 trial in crc